Evidence mapPaperPMID 41764340Full record

ArticleScientific reports2026

Integrative ensemble learning framework for forecasting controlled drug release based on Raman spectral signatures.

Ahmed H Albariqi, Awaji Y Safhi, Saad S Alqahtani, Fahad Y Sabei, Mahboubeh Pishnamazi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed H AlbariqiDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, 45142, Saudi Arabia.
Awaji Y SafhiDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, 45142, Saudi Arabia.
Saad S AlqahtaniClinical Pharmacy Department, College of pharmacy, King Khalid University, Abha, Saudi Arabia.
Fahad Y SabeiDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, 45142, Saudi Arabia.
Mahboubeh PishnamaziInstitute of Research and Development, Duy Tan University, Da Nang, Vietnam. mahboubehpishnamazi@duytan.edu.vn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modeling drug-release kinetics from polysaccharide-coated oral controlled-release formulations remains challenging due to nonlinear diffusion–dissolution behavior, complex polymer–drug interactions, and the limited interpretability of conventional machine-learning approaches. In this study, we develop and validate a predictive framework for targeted colonic delivery of 5-aminosalicylic acid (5-ASA) from polysaccharide-coated solid oral dosage forms using Raman spectroscopy–derived molecular fingerprints and time-resolved dissolution data. The dataset comprises 155 formulation samples, each characterized by more than 1,500 Raman spectral features, categorical formulation variables (polysaccharide type and release medium), and drug-release measurements at 2, 8, and 24 h collected under simulated physiological conditions. A dual-optimizer, dual-ensemble learning strategy is introduced, integrating the Puma Optimizer Algorithm (POA) and Black-Winged Kite Algorithm (BWKA) within a Damsphere Weighted Ensemble (DWE) of XGBoost regression and AdaBoost models. The complementary exploration–exploitation dynamics of the two optimizers enhance convergence stability and generalization, yielding strong predictive performance under five-fold cross-validation (RMSE = 0.038; R2 = 0.991). Feature-level analysis based on F-statistics highlights release time, dissolution medium, and chemically meaningful Raman bands as dominant predictors, consistent with diffusion- and erosion-controlled release mechanisms in polysaccharide-coated systems. From a pharmaceutical perspective, the proposed framework reduces experimental burden while maintaining mechanistic interpretability, supporting Quality by Design (QbD) and green pharmaceutics principles. Owing to its modular architecture, the approach is readily extensible to other polymer-based oral controlled-release formulations and spectroscopic modalities.

Indexed as

Delayed-Action PreparationsDrug LiberationMachine LearningMesalamineSpectrum Analysis, RamanAlgorithmsBoosting Machine Learning AlgorithmsPolysaccharidesPrediction AlgorithmsDelayed-Action PreparationsMesalaminePolysaccharidesControlled drug deliveryDiffusion-controlled kineticsPolymer–drug interactionsPolysaccharide-based drug releaseProcess analytical technologyStatistical validation

Identifiers

PMID41764340
PMCPMC13049152

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.